I-1.HKU yathi iyeza lempumlo le-COVID-19 kunye nesitofu sokugonya umkhuhlane sinokudityaniswa ibe nye.
iye ngeempumlo isitofu se-COVID-19 esiphuhliswe ngokudibeneyo yiYunivesithi yaseHong Kong, iYunivesithi yaseXiamen kunye neBeijing Wantai Biological Pharmaceutical Co., Ltd. isandula kuvunywa nguLawulo lweZiyobisi lweState ukuze isetyenziswe ngokungxamisekileyo kwilizwekazi.IYunivesithi yaseHong Kong yaphendula kumbuzo weNtatheli yeNkonzo yase-China yokuba enye yeempawu zesitofu sokugonya se-COVID-19 sempumlo kukuba sinokudityaniswa nesitofu sokugonya somkhuhlane.
I-2.Waterloo, i-3 yeebhiliyoni ezahlukeneyo, idale "isithsaba sokuthengisa" esitsha se-antiemetics!
I-nausea kunye nokuhlanza okubangelwa yi-chemotherapy yenye yezona zinto zixhaphakileyo zokusabela kwizigulane ezinomhlaza.Anti emetics kunye namachiza anti isicaphucaphu zihlelwa njengoko inkqubo yokwetyisa kunye namachiza metabolic, kodwa ikakhulu zisetyenziswa kunyango lokugabha okubangelwa amachiza anti-ithumba kuqheliselo lwezonyango, kwaye badlale indima ebalulekileyo entsimini unyango ithumba.Ngokutsho kwedatha evela kwi-Minei.com, ubungakanani bentengiso ye-antiemetics kunye ne-antinausea yamachiza kwii-terminals zamaziko onyango karhulumente e-China kwisiqingatha sokuqala se-2022 idlule i-2.9 yebhiliyoni ye-yuan.IQilu Pharmaceutical iqhubekile nokukhokela imarike.Iqela leZhengda Tianqing Pharmaceutical Group likhawulezele kwi-TOP2.I-Hengrui Class 1 yamachiza amatsha angenile kwiSigaba sesi-III kuqheliselo lwezonyango, kwaye umjikelo omtsha wokutshintsha uphawu sele uza kuqalisa.
3.Double anti R&D track ishushu!I-Xinda kunye nezinye iinkampani zifumene imarike exabisa ngaphezu kwe-200 yeebhiliyoni
Kutshanje, imarike yamachiza echasene neziyobisi ibishushu: iKangfang Biotech kunye neSummit Therapeutics ifikelele kwintengiselwano yelayisensi yaphesheya ukuya kuthi ga kwi-5 yeebhiliyoni zeedola zaseMelika kwimveliso echasene neziyobisi i-AK112, kunye neWuhan Youzhiyou Biotech, uphando lwasekhaya oluchasene neziyobisi kunye nophuhliso. ishishini, lingenise isicelo salo soluhlu lwe-IPO… Iqhutywa yimarike evumayo, ichiza elichasayo eliphindwe kabini liyalwamkela uphando kunye nophuhliso lwe-boom.Okwangoku, kukho malunga ne-80 yeentlobo ze-antibodies eziphindwe kabini kwinqanaba lekliniki e-China.I-Xinda Bio, i-Shiyao Holding, i-Roche, njl njl zineemveliso ezine okanye ngaphezulu phantsi kophando.Iimveliso ezilishumi elinesithathu zeHengrui Pharmaceutical, ezifana ne-SHR-1701, i-Baiji Shenzhou's Zanidatamab, zikwisigaba sesi-III seklinikhi.Izilwa-buhlungu kabini ezisekwe kwi-CD47/PD-L1 ekujoliswe kuzo zezona zidumileyo, kwaye iimveliso ezintlanu ziphantsi kolingo lwezonyango.I-CDE iye yaqulunqa uluhlu lwemigaqo ekhokelayo kwimiba efuna ingqwalasela engxamisekileyo kuphando lwezonyango kunye nophuhliso lwamachiza alwa nethumba aphindiweyo, Ukukhokela amashishini ukuba enze uphando lwezonyango lwenzululwazi ngakumbi kunye nophuhliso lwe-anti-tumor ephindwe kabini.
4.Esona sifo sibi kakhulu somkhuhlane kule minyaka ilishumi idlulileyo siye sabetha!Inani labalaliswa esibhedlele kumazwe ase-US lenyukile
Ngokwengxelo yexesha le-5 lendawo ye-Axios, iwebhusayithi yeendaba yase-US, owona mkhuhlane umbi kakhulu kwisithuba esingaphezulu kweminyaka elishumi ubethe inkqubo yezonyango kunye nezempilo esele ikwicala lokuwa ngenxa yobhubhani we-COVID-19 kunye ne-syncytial yokuphefumla. intsholongwane (RSV).
Kuxelwe ukuba umkhuhlane wenze phantse wonke urhulumente kwinqanaba eliphezulu okanye eliphezulu kakhulu lomsebenzi womkhuhlane.
Ngokutsho kwamaZiko e-US oLawulo lweSifo kunye noThintelo (CDC), inani lokulaliswa kwezibhedlele ezinxulumene nomkhuhlane ngexesha le-Thanksgiving liphantse liphindwe kabini ukusuka kwiveki edlulileyo, elona liphezulu ukususela kwixesha lomkhuhlane we-2010-2011.Phakathi kwabo, abantu abadala abaneminyaka eyi-65 nangaphezulu kunye nabantwana abaneminyaka eyi-4 nangaphantsi bachaphazeleka kakhulu, ngakumbi ukuba baneengxaki zempilo.
Nangona kunjalo, malunga ne-40% yabantu baseMelika bathi abacwangcisanga ukugonya umkhuhlane ngeli xesha lonyaka, ngakumbi ngenxa yokuba babenexhala malunga nesiphumo esibi okanye iziphumo ebezingalindelekanga zesitofu sokugonya.
Iingcali zempilo yoluntu zithi kule minyaka mibini idlulileyo, iimaski kunye nezinye iindlela zokuthintela ubhubhane we-COVID-19 ziye zawunqanda kakhulu umkhuhlane kwaye zathintela usulelo lwawo ngamaxesha athile onyaka.Nangona kunjalo, njengokuba abantu bebuyela kubomi babo bangaphambi kobhubhani, basesichengeni sosulelo.
Kunyaka ophelileyo, iqela lophando laqikelela ukuba xa amanyathelo okuzikhusela esusiwe, imeko yobhubhane yabantwana iya kuphinda iphindeke kakhulu.Abaphandi babongoze ukuphunyezwa kwesicwangciso esiqinileyo "sokugonywa kokulandela".
I-CDC iqikelela ukuba, ukuza kuthi ga ngoku, ubuncinci abantu abazizigidi ezisisi-8.7 baye bagula, abangama-78000 balaliswe esibhedlele kwaye abangama-4500 basweleke ngexesha lomkhuhlane.
Ngokutsho kwe-CNN, urhulumente we-Biden uthembise ukubonelela ngezixhobo kunye nabasebenzi ukunceda inkqubo yezempilo yasekhaya ukumelana nokuqhambuka komkhuhlane, kodwa akazukuqwalasela ukubhengeza imeko kaxakeka yezempilo yoluntu.
Ngokwedatha ye-CDC, phakathi kuka-2009 kunye no-2022, izinga lokulaliswa esibhedlele kumkhuhlane wabantu abadala base-Afrika baseMelika liphantse libe ngama-80% aphezulu kunowabantu abadala abamhlophe.Nangona kunjalo, ngexesha lomkhuhlane we-2021-2022, ngaphantsi kwe-43% yabantu abadala base-Afrika baseMelika, i-Hispanic kunye ne-Native American yaseMelika baye bagonywa.
Kwileta eyayisiya kumazwe, uNobhala weSebe lezeMpilo laseMelika kunye neeNkonzo zoLuntu, uXavier Bessela, wabhala ukuba urhulumente wobumbano unokungenelela ukunceda inkqubo yezonyango ejongene noxinzelelo, njengokuvumela izibhedlele ezinqongopheleyo zabasebenzi ukuba zonwabele ukukhululwa ekonyukeni. ukukwazi ukunyanga izigulana, okanye ukubenza ukuba kunokwenzeka ukuba bagqithisele abaguli abanomkhuhlane, i-COVID-19 okanye i-RSV.
JinDun Medicalinentsebenziswano yexesha elide yophando lwezenzululwazi kunye neteknoloji yokuxhunyelelwa kwiiyunivesithi zaseTshayina.Ngezixhobo zonyango ezityebileyo zikaJiangsu, inobudlelwane bexesha elide kunye neIndiya, iSoutheast Asia, iSouth Korea, iJapan kunye nezinye iimarike.Ikwabonelela ngeenkonzo zentengiso kunye nentengiso kuyo yonke inkqubo ukusuka phakathi ukuya kwimveliso egqityiweyo ye-API.Sebenzisa izibonelelo eziqokelelweyo zeYangshi Chemical kwichemistry fluorine ukubonelela ngeenkonzo ezizodwa zokwenza imichiza kumaqabane.Ukubonelela ngenkqubo yokuveliswa kwezinto ezintsha kunye neenkonzo zophando lokungcola kubathengi abajoliswe kuyo.
I-JinDun Medical igxininisa ekudaleni iqela elinamaphupha, ukwenza iimveliso ngesidima, ubuqili, ubukhali, kwaye uphume wonke ube liqabane elithembekileyo kunye nomhlobo wabathengi! Ababoneleli besisombululo esisodwa, i-R&D elungiselelweyo kunye neenkonzo zemveliso ezilungiselelwe abaphakathi bamayeza kunye nee-APIs, yobuchwepheshaimveliso yamayeza elungiselelweyo(CMO) kunye nababoneleli ngeenkonzo zeR&D kunye nemveliso (CDMO).UJindun uya kukukhapha ukuya kuchitha i-COVID-19.
Ixesha lokuposa: Dec-16-2022